Gratia Capital’s LifeMD LFMD Stock Holding History

Gratia Capital’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,000	Closed	-$435K	–	34
2021 Q3	$435K	Buy	+70,000	New	+$597K	0.36%	32

Other funds holding LFMD

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIA

Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gratia Capital's LFMD Position: Q4 2021 in Review

Gratia Capital sold out of LifeMD (LFMD) in Q4 2021, closing a stake of 70,000 shares — an estimated $435K sold.

Gratia Capital first reported a position in LFMD in Q3 2021 and held it in 1 quarter. The position peaked at $435K in Q3 2021. 53 funds tracked by Wall St. Rank hold LFMD as of Q4 2021.

Gratia Capital reported no remaining LifeMD position as of Q4 2021 after selling out during the quarter.
Gratia Capital sold 70,000 LifeMD shares in Q4 2021, an estimated $435K.
Gratia Capital first reported a position in LifeMD in Q3 2021 and held it in 1 quarter.
Gratia Capital's LifeMD position peaked at $435K in Q3 2021.
53 funds tracked by Wall St. Rank held LifeMD as of Q4 2021.

Based on Gratia Capital's 13F filing for Q4 2021, filed 14 Feb 2022.